Beximco Pharma warns of ‘little to no revenues’ from Covid-19 jab deal with Bangladesh

Beximco Pharmaceutical shares have slipped after the company warned of “little to no revenues” from its deal with the government of Bangladesh for Covid-19 vaccines. The London-listed company, which last year sealed the deal for a majority stake in Sanofi’s Bangladeshi business, had been supplying the AztraZeneca/ Oxford vaccine to the government of Bangladesh (GOB). [...]